Rosner Elimelech 4

What Happened
Elimelech Rosner, EVP and Chief Technology Officer of HealthEquity, received two restricted stock unit (RSU) awards on March 25, 2026 totaling 60,607 RSUs (19,704 RSUs and 40,903 RSUs). Both awards show an acquisition price of $0.00 (code A — grant/award). The filing notes that 40,903 of those RSUs vested on March 25, 2026; the remaining 19,704 RSUs are subject to a future vesting schedule.

Key Details

• Transaction date(s): March 25, 2026 (Form 4 filed March 27, 2026). Filing appears timely.
• Transaction code and price: A (award/grant); price $0.00 per RSU.
• Share counts: 19,704 RSUs (subject to future vesting); 40,903 RSUs vested on March 25, 2026. Total awarded: 60,607 RSUs.
• Post-transaction shares owned: Not disclosed in the excerpt of the filing.
• Footnotes:
  • F1: Each RSU converts into one share. The 19,704 RSUs vest 25% on April 1, 2027 and 6.25% on the first day of each calendar quarter for the next 12 quarters.
  • F2: The 40,903 RSUs vested on March 25, 2026.
• Administrative note: Power of Attorney referenced was previously filed (July 7, 2023) and is incorporated by reference.

Context
RSUs are a form of equity compensation — not a cash purchase — and represent a contingent right to receive common stock upon vesting. The immediate vesting of 40,903 RSUs means those units converted to shares (or the right to shares) on March 25, 2026; the remaining 19,704 RSUs will vest over time per the schedule in F1. Awards and vesting are common forms of executive compensation and do not by themselves indicate a buy or sell decision.